Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion type Assertion NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_head.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion description "[In two MET-amplified human gastric tumor xenograft models, SNU-5 and Hs 746T, intravenous treatment with SAR125844 leads to potent, dose- and time-dependent inhibition of the MET kinase and to significant impact on downstream PI3K/AKT and RAS/MAPK pathways.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion evidence source_evidence_literature NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion SIO_000772 25504634 NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion wasDerivedFrom befree-2016 NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.
- NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_assertion wasGeneratedBy ECO_0000203 NP1248073.RAyvJNqPl3l2KLImN6qf-RFtFUlrT7f8f74kigK53Snto130_provenance.